Stocks-UTHR-United Therapeutics Corp

UTHR United Therapeutics Corp

0 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: United Therapeutics Corp's revenues increased by 14.88% and amounted to 1.94B. Net income increased by 52.86% to 727.30M. Net assets decreased by NaN to N/A and EPS decreased from N/A to 15.00.
UTHR's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
88.87%
Net Profit Margin
23.32%
Operating Margin
49.92%
Return On Investment
8.04%